Cryptococcal epidemiology is changing in the modern anti-retroviral era, and immune status informs outcomes. We describe the differences in clinical presentation and mortality of cryptococcosis by immune status in the ART era.
Cryptococcal epidemiology is changing in the modern anti-retroviral era, and immune status informs outcomes. We describe the differences in clinical presentation and mortality of cryptococcosis by immune status in the ART era.